日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Belimumab concentrations and immunogenicity in relation to drug effectiveness and safety in SLE within a Swedish real-world setting

在瑞典真实世界环境中，贝利木单抗的浓度和免疫原性与系统性红斑狼疮（SLE）的药物疗效和安全性之间的关系

期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/keaf128
Gomez, Alvaro; Walhelm, Tomas; Loeff, Floris C; Jönsen, Andreas; Nikolopoulos, Dionysis; van den Broek, Bryan; Bengtsson, Anders A; de Vries, Annick; Rispens, Theo; Sjöwall, Christopher; Parodis, Ioannis
红斑狼疮
免疫/内分泌
发表日期：2025
文献求助 收藏

Comorbid psoriasis in systemic lupus erythematosus: a cohort study from a tertiary referral centre and the National Patient Register in Sweden

系统性红斑狼疮合并银屑病：一项来自瑞典三级转诊中心和国家患者登记处的队列研究

期刊:Lupus Science & Medicine
影响因子:3.5
doi:10.1136/lupus-2025-001504
Walhelm, Tomas; Parodis, Ioannis; Enerbäck, Charlotta; Arkema, Elizabeth; Sjöwall, Christopher
银屑病
红斑狼疮
免疫/内分泌
发表日期：2025
文献求助 收藏

Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study

蛋白酶体抑制剂硼替佐米治疗重症系统性红斑狼疮的疗效和安全性临床经验：一项全国性研究

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2021.756941
Walhelm, Tomas; Gunnarsson, Iva; Heijke, Rebecca; Leonard, Dag; Trysberg, Estelle; Eriksson, Per; Sjöwall, Christopher
红斑狼疮
免疫/内分泌
发表日期：2021
文献求助 收藏

Longitudinal Analysis of Anti-cardiolipin and Anti-β2-glycoprotein-I Antibodies in Recent-Onset Systemic Lupus Erythematosus: A Prospective Study in Swedish Patients

近期发病系统性红斑狼疮患者抗心磷脂抗体和抗β2糖蛋白-I抗体的纵向分析：一项瑞典患者的前瞻性研究

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2021.646846
Frodlund, Martina; Walhelm, Tomas; Dahle, Charlotte; Sjöwall, Christopher
红斑狼疮
免疫/内分泌
发表日期：2021
文献求助 收藏